April 20th. We are going to attend the 19th Annual Anglonordic Life Science Conference.
Meet us to discuss face to face about our latest works: CA04 first-in-class monoclonal antibody, CA05 first-in-class kinase inhibitor and CA07 novel PROTAC.
We can’t wait to hear from you.
CancerAppy closed 2022 with €1.3M total raised.
CancerAppy closed 2021 with €690K total raised.
The Ministry of Science and Technology has granted Torres Quevedo research grant for our researcher Elisa Poyatos.
CancerAppy raised a pre-seed round of € 50K
Enisa has granted us a loan of 100K
